Neutral impactEconomy
Indian Pharma Steps Up AI Push in Drug Discovery, But Investment Gap With Global Peers Persists
NDTV Profit 1 hr ago·28 Jul 2026, 9:45 am
Indian pharmaceutical companies are increasingly integrating artificial intelligence into their research and development processes to speed up drug discovery. This modern approach allows firms to analyze vast amounts of data more efficiently, potentially identifying new treatments faster than traditional methods. While this technological shift is gaining momentum domestically, the overall investment in AI-driven discovery remains significantly lower compared to major global players and China.
For investors, this trend signals a growing modernization of the sector, which could lead to higher efficiency and innovation in the future. However, the substantial funding gap suggests that Indian companies are still in the early stages of adopting these advanced tools compared to their international counterparts. This disparity highlights a potential area for future growth and competitive advantage.
Investors should monitor the pace of AI adoption and the specific R&D budgets allocated by leading firms. Tracking which companies successfully bridge this investment gap could reveal opportunities in a rapidly evolving market. Keeping an eye on regulatory approvals and technological breakthroughs will also be key to understanding the sector's long-term trajectory.
Key takeaways
- Category: Economy.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
